SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-129186
Filing Date
2023-12-26
Accepted
2023-12-26 16:05:25
Documents
1
Period of Report
2023-12-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2333679-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2333679-1_4seq1.xml 4 5880
  Complete submission text file 0001104659-23-129186.txt   7504
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CYCLACEL PHARMACEUTICALS, INC. 200 CONNELL DRIVE, SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address
McBarron Paul (Reporting) CIK: 0001357397 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 231513361